NFE2L2 and hematoma: Just as displayed in Table 5, as compared to patients without risk of poor prognosis, those, who were likely to experience poor prognosis, had significantly raised percentages of intraventricular bleedings and subarachnoid bleedings (both P < 0.01) and were more prone to exhibit significantly increased NIHSS scores (P < 0.001), hematoma volume (P < 0.001), blood glucose levels (P < 0.05), and serum Nrf2 levels (P < 0.001).